{
    "10201555":
    {
        "question": "Is low serum chloride level a risk factor for cardiovascular mortality?",
        "llm_evidence": "Low serum chloride levels have been associated with various health issues, including an increased risk of cardiovascular mortality. Several studies suggest that chloride is essential for maintaining proper fluid balance and cellular function, and derangements can lead to potential cardiovascular complications. Hypochloremia, or low chloride levels, may indicate underlying conditions such as metabolic alkalosis, renal dysfunction, and heart failure. A study published in a reputable journal found that low serum chloride levels in hospitalized patients were independently linked to higher mortality rates, particularly in those with existing cardiovascular disease. Additionally, low chloride has been associated with adverse outcomes in patients with coronary artery disease. The evidence highlights that monitoring serum chloride levels could be crucial for identifying individuals at higher risk for cardiovascular complications and mortality.",
        "paper_evidence":
        [
            "Serum chloride level is routinely assayed in clinical laboratories in the management of patients with kidney disorders and with metabolic diseases. It is a biological parameter that is easily, precisely and relatively cheaply measured. The epidemiological features of serum chloride levels have not been studied before.",
            "For the random sample of men and women from the Belgian Interuniversity Research on Nutrition and Health aged 25-74 years, free of symptomatic coronary heart disease at baseline, serum chloride concentrations were measured, among those of other electrolytes. The cohort was followed up for 10 years with respect to subsequent cause-specific mortality.",
            "The results are based on observations of 4793 men and 4313 women. According to Cox regression analysis serum chloride level was one of the strongest predictors of total, cardiovascular disease (CVD) and non-CVD mortalities independently of age, body mass index, sex, smoking, systolic blood pressure, levels of total and high-density lipoprotein cholesterol, uric acid, serum creatinine and serum total proteins and intake of diuretics. This relation was proved to be independent of levels of other serum electrolytes and similar for men and women. The estimated adjusted risk ratio for CVD death for subjects with a serum chloride level<or =100 mmol/l compared with those with levels above that limit was 1.65 (95% confidence interval 1.06-2.57) for men and 2.16 (95% confidence interval 1.11-4.22) for women. The study of adjusted risk ratios for four groups of subjects defined on the basis of their baseline serum chloride levels revealed a decreasing log-linear 'dose-response' relation to total and cardiovascular mortalities."
        ]
    },
    "17565137":
    {
        "question": "Out of the smokescreen II: will an advertisement targeting the tobacco industry affect young people's perception of smoking in movies and their intention to smoke?",
        "llm_evidence": "Recent research indicates that advertisements targeting the tobacco industry can significantly influence young people's perceptions of smoking in movies and their intention to smoke. Key insights include:\n\n1. **Brand Awareness and Normalization**: Advertisements that highlight the negative consequences of smoking can enhance awareness of tobacco industry tactics, thus making young viewers more critical of smoking portrayals in films. This increased awareness may counteract the normalization of smoking that often occurs through glamorized depictions.\n\n2. **Impact on Attitudes**: Studies have shown that targeted campaigns raise awareness about the risks associated with smoking and the manipulative practices of tobacco companies. As a result, young viewers may develop stronger negative attitudes towards smoking, reducing their likelihood of imitation.\n\n3. **Behavioral Intention**: Exposure to anti-tobacco advertisements has been linked to a decrease in intention to smoke among adolescents. Such campaigns often lead to a greater understanding of the harmful effects of smoking and the influence of media portrayal, which can shift their behavioral intentions away from smoking.\n\n4. **Social Influences**: By providing young people with the language and tools to critique smoking in media, these advertisements can diminish peer influence and the desire to smoke as a social norm, making them more resistant to smoking behaviors.\n\nOverall, effective advertising campaigns that target the tobacco industry can play a crucial role in shaping young peopleâ€™s perceptions and reducing their intention to smoke by fostering critical awareness and altering attitudes towards smoking in films.",
        "paper_evidence":
        [
            "To evaluate the effect of an antismoking advertisement on young people's perceptions of smoking in movies and their intention to smoke.SUBJECTS/",
            "3091 cinema patrons aged 12-24 years in three Australian states; 18.6% of the sample (n = 575) were current smokers.DESIGN/",
            "Quasi-experimental study of patrons, surveyed after having viewed a movie. The control group was surveyed in week 1, and the intervention group in weeks 2 and 3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was shown, shot in the style of a movie trailer that warned patrons not to be sucked in by the smoking in the movie they were about to see.",
            "Attitude of current smokers and non-smokers to smoking in the movies; intention of current smokers and non-smokers to smoke in 12 months.",
            "Among non-smokers, 47.8% of the intervention subjects thought that the smoking in the viewed movie was not OK compared with 43.8% of the control subjects (p = 0.04). However, there was no significant difference among smokers in the intervention (16.5%) and control (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention group indicated that they were likely to be smoking in 12 months time (38.6%) than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no significant difference in smoking intentions between groups, with 1.2% of intervention subjects and 1.6% of controls saying that they would probably be smoking in 12 months time (p = 0.54)."
        ]
    },
    "18041059":
    {
        "question": "Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?",
        "llm_evidence": "Adjuvant aromatase inhibitors (AIs) are commonly used in postmenopausal women with early-stage estrogen receptor-positive breast cancer to reduce the risk of recurrence. However, their impact on cardiovascular risk has been a subject of research. \n\nSeveral clinical studies and meta-analyses have shown that while aromatase inhibitors can significantly improve breast cancer outcomes, they may also lead to an increased risk of cardiovascular events. Notably, AIs are associated with side effects such as hypertension, dyslipidemia, and metabolic syndrome, which are known cardiovascular risk factors. For instance, a study published in the Journal of Clinical Oncology indicated that postmenopausal women receiving AIs experienced higher rates of cardiovascular events compared to those on tamoxifen.\n\nFurthermore, while some evidence suggests that the overall benefits of AIs in breast cancer recurrence may outweigh the cardiovascular risks, it is crucial for healthcare providers to monitor cardiovascular health in patients on these therapies. Lifestyle modifications and preemptive management of cardiovascular risk factors could help mitigate these risks.\n\nIn summary, adjuvant aromatase inhibitors do appear to increase cardiovascular risk in postmenopausal women with early breast cancer, warranting careful cardiovascular monitoring and management in this patient population.",
        "paper_evidence":
        [
            "Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated.",
            "Phase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined.",
            "Seven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed."
        ]
    },
    "22154448":
    {
        "question": "Epidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?",
        "llm_evidence": "Epidural analgesia (EA) is a technique often used to manage pain during and after surgical procedures, including those for peritoneal carcinomatosis. While it offers advantages such as reduced opioid consumption and enhanced postoperative recovery, it does carry certain risks. Key insights include:\n\n1. **Risk of Complications**: Epidural analgesia can lead to complications such as infection, hematoma formation, or neurological injury. These risks may be particularly concerning in patients with peritoneal carcinomatosis, who often have compromised physiology and may undergo complex surgical procedures.\n\n2. **Coagulation Considerations**: Patients with peritoneal carcinomatosis may require anticoagulation therapy to manage associated risks. The combination of EA and anticoagulants elevates the risk of spinal hematoma, a potentially serious complication.\n\n3. **Impact on Mobilization**: While EA can provide effective pain relief, it may affect a patient's ability to mobilize after surgery. Mobilization is critical for recovery, especially in oncological surgery, where early movement can reduce the risk of complications like deep vein thrombosis and pulmonary embolism.\n\n4. **Effectiveness**: Evidence suggests that EA can enhance analgesia in patients undergoing colorectal surgeries, which may include peritoneal carcinomatosis cases. However, the effectiveness and safety balance requires careful patient selection and monitoring.\n\nIn conclusion, while epidural analgesia can be beneficial in managing postoperative pain for surgical treatment of peritoneal carcinomatosis, it is important to weigh the risks and proactively manage potential complications related to this technique.",
        "paper_evidence":
        [
            "To study the risks of haemodynamic instability, and the possible occurrence of spinal haematoma, meningitis and epidural abscess when epidural analgesia is performed for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).",
            "We retrospectively analyzed the data of 35 patients treated by HIPEC with oxaliplatin or cisplatin. An epidural catheter was inserted before induction of general anaesthesia. Postoperatively, a continuous epidural infusion of ropivacain, then a patient-controlled epidural analgesia were started.",
            "The epidural catheter was used peroperatively before HIPEC in 12 subjects (34%), and after HIPEC in 23 subjects (66%). The median dose of ropivacain given peroperatively in the epidural catheter was 40 mg (30-75). Norepinephrin was used in two subjects (6%) peroperatively (median infusion rate 0.325 Î¼g/kg per minute [0.32-0.33]), and in four subjects (11%) in the postoperative 24 hours. No spinal haematoma, meningitis or epidural abscess were noted. Five subjects (14%) had a thrombopenia or a prothrombin time less than 60% before catheter removal. Two subjects (6%) had a leukopenia before catheter removal. No thrombopenia or blood coagulation disorders were recorded the day of catheter removal."
        ]
    },
    "25280365":
    {
        "question": "Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians?",
        "llm_evidence": "In the realm of hematology, the interpretation of red blood cell (RBC) morphology often reveals discrepancies between clinical pathologists and clinicians due to varying levels of training, experience, and focus on different aspects of patient management. Clinical pathologists typically have extensive training in laboratory diagnostics and are more attuned to subtle morphological changes, making their assessments detailed and nuanced. In contrast, clinicians, while familiar with blood work, may prioritize the overall clinical picture and therapeutic implications over specific morphological details.\n\nEvidence from studies indicates that discordance often occurs in cases of borderline or atypical findings, such as anemias with overlapping features, where pathologists may identify changes that clinicians may not prioritize or understand in the context of patient care. Additionally, communication gaps between the two groups can exacerbate misunderstandings regarding the implications of certain morphologies, leading to divergent treatment approaches. \n\nAutomated blood analysis systems, while beneficial for standardizing results, can also contribute to this discordance by providing normative data that may not capture the clinical complexity of individual cases. Ultimately, fostering interdisciplinary communication and education regarding RBC morphology can bridge these gaps, leading to improved patient outcomes.",
        "paper_evidence":
        [
            "Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to assist clinicians in prioritizing differential diagnoses. However, reporting is subjective, semiquantitative, and potentially biased. Reporting decisions vary among CPs, and reports may not be interpreted by clinicians as intended.",
            "The aims of this study were to survey clinicians and CPs about RBC-M terms and their clinical value, and identify areas of agreement and discordance.",
            "Online surveys were distributed to small animal clinicians via the Veterinary Information Network and to CPs via the ASVCP listserv. A quiz assessed understanding of RBC-M terms among respondent groups. Descriptive statistics were used to analyze responses to survey questions, and quiz scores were compared among groups.",
            "Analyzable responses were obtained from 1662 clinicians and 82 CPs. Both clinicians and CPs considered some terms, e.g., agglutination, useful, whereas only CPs considered other terms, e.g., ghost cells, useful. All groups interpreted certain terms, e.g., Heinz bodies, correctly, whereas some clinicians misinterpreted others, e.g., eccentrocytes. Responses revealed that CPs often do not report RBC-M they consider insignificant, when present in low numbers. Twenty-eight percent of clinicians think CPs review all blood smears while only 19% of CPs report reviewing all smears."
        ]
    },
    "23571528":
    {
        "question": "Sternal skin conductance: a reasonable surrogate for hot flash measurement?",
        "llm_evidence": "Sternal skin conductance is increasingly recognized as a potential surrogate for measuring hot flashes, especially in clinical and research settings. Key insights include:\n\n1. **Physiological Basis**: Skin conductance reflects sweat gland activity, which is activated during hot flashes due to autonomic nervous system changes. This response is particularly pronounced in the sternal region, making it a targeted site for measurement.\n\n2. **Correlation with Symptoms**: Studies have shown a strong correlation between changes in sternal skin conductance and self-reported hot flash episodes, offering a quantifiable metric to assess the frequency and intensity of these episodes.\n\n3. **Non-invasive Method**: Measuring sternal skin conductance is non-invasive and allows for real-time monitoring, providing advantages over traditional subjective assessment tools, such as diaries or questionnaires.\n\n4. **Clinical Utility**: The use of skin conductance as a surrogate has been validated in various studies, suggesting it can enhance the understanding of hot flash mechanisms and potentially guide treatment efficacy in hormonal and non-hormonal interventions.\n\nOverall, the evidence supports that sternal skin conductance can serve as a reliable and objective method for hot flash measurement, reinforcing its application in both clinical practice and research scenarios.",
        "paper_evidence":
        [
            "This study aims to examine the accuracy of a new sternal skin conductance (SSC) device in measuring hot flashes and to assess the acceptability of the device by women.",
            "Three small descriptive pilot studies were performed using two sequential prototypes of the SSC device developed by an engineering device company in the Midwest. The devices were worn either in a monitored setting for 24 hours or in an ambulatory setting for 5 weeks. During the study period, women recorded hot flashes in a prospective hot flash diary and answered questions about the acceptability of wearing the SSC device.",
            "The first prototype was not able to collect any analyzable skin conductance data owing to various malfunction issues, including poor conductance and battery failure. However, 16 women wore the device for 5 weeks and reported that wearing the device was acceptable, although 31% stated that it interfered with daily activities. Hot flash data from the second prototype revealed a 24% concordance rate between self-reported and device-recorded hot flashes."
        ]
    },
    "21394762":
    {
        "question": "Is pelvic pain associated with defecatory symptoms in women with pelvic organ prolapse?",
        "llm_evidence": "Pelvic organ prolapse (POP) is a condition commonly seen in women that can lead to various symptoms, including pelvic pain and defecatory dysfunction. Research indicates a significant relationship between pelvic pain and defecatory symptoms in women with POP. Key insights include:\n\n1. **Common Symptoms**: Women with POP often report pelvic pain, which can be multifactorial, and a prevalent symptom is difficulty with bowel movements or incomplete evacuation.\n\n2. **Anatomical and Functional Impact**: The anatomical changes associated with POP, such as descending pelvic organs, can exert pressure on the rectum and disrupt normal bowel function, leading to defecatory symptoms.\n\n3. **Psychosocial Factors**: Pelvic pain can also be exacerbated by psychological aspects, including anxiety and depression, which can influence both pain perception and defecatory symptoms.\n\n4. **Clinical Findings**: Studies show that women with more severe prolapse are more likely to experience both pelvic pain and rectal issues, emphasizing a correlation between the severity of prolapse and the coexistence of these symptoms.\n\n5. **Therapeutic Implications**: Understanding the link between pelvic pain and defecatory symptoms is crucial for developing comprehensive treatment plans. Interventions targeting pelvic pain may simultaneously alleviate constipation or other defecatory disorders associated with prolapse.\n\nIn conclusion, there is strong evidence to suggest that pelvic pain is associated with defecatory symptoms in women with pelvic organ prolapse, highlighting the importance of evaluating both dimensions in clinical settings.",
        "paper_evidence":
        [
            "To investigate the significance of pelvic pain and its association with defecatory symptoms in women with pelvic organ prolapse (POP).",
            "This is a cross sectional study of 248 women with stage II POP or greater. Women were stratified into \"pain\" and \"no-pain\" groups based on their response to a question on the Pelvic Floor Distress Inventory short form. Associations between patient demographics, exam findings and responses to validated questionnaires were evaluated.",
            "In women with POP, defecatory symptoms are significantly more common in women with pelvic pain including straining with bowel movement (OR 2.4, 95% CI 1.3, 4.6), sense of incomplete emptying (OR 4.4, 95% CI 2.3, 8.2), pain with bowel movement (OR 5.3, 95% CI 1.2, 23.0) and splinting with bowel movement (OR 3.8, 95% CI 2.0, 7.5)."
        ]
    },
    "25571931":
    {
        "question": "Do elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke?",
        "llm_evidence": "Elderly patients often underutilize emergency services like 911 when experiencing symptoms indicative of acute stroke, primarily due to factors such as misinterpretation of symptoms, fear of causing a false alarm, and a lack of awareness regarding the urgency of timely medical intervention for strokes. Studies show that while the FAST (Face, Arm, Speech, Time) protocol is widely publicized, many older adults may not recognize their symptoms as needing immediate help or may assume their symptoms will resolve on their own. Additionally, social factors, such as living alone or having limited access to transportation, can further hinder their ability to reach emergency services promptly. Consequently, awareness campaigns geared towards elderly populations are crucial in encouraging timely 911 calls during potential stroke presentations.",
        "paper_evidence":
        [
            "Among patients with acute stroke symptoms, delay in hospital admission is the main obstacle for the use of thrombolytic therapy and other interventions associated with decreased mortality and disability. The primary aim of this study was to assess whether an elderly clinical population correctly endorsed the response to call for emergency services when presented with signs and symptoms of stroke using a standardized questionnaire.",
            "We performed a cross-sectional study among elderly out-patients (â‰¥60 years) in Buenos Aires, Argentina randomly recruited from a government funded health clinic. The correct endorsement of intention to call 911 was assessed with the Stroke Action Test and the cut-off point was set at â‰¥75%. Knowledge of stroke and clinical and socio-demographic indicators were also collected and evaluated as predictors of correct endorsement using logistic regression.",
            "Among 367 elderly adults, 14% correctly endorsed intention to call 911. Presented with the most typical signs and symptoms, only 65% reported that they would call an ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). On average, the correct response was chosen only 37% of the time. Compared to lower levels of education, higher levels were associated to correctly endorsed intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21)."
        ]
    },
    "23621776":
    {
        "question": "Does a history of unintended pregnancy lessen the likelihood of desire for sterilization reversal?",
        "llm_evidence": "Research indicates that individuals with a history of unintended pregnancies may have a complex relationship with their desire for sterilization reversal. A history of unintended pregnancy can lead to heightened awareness of the challenges and consequences of unplanned parenthood, which might contribute to an increased desire for reproductive control, including the reversal of sterilization. However, some studies suggest that those who have experienced unintended pregnancies may also display ambivalence about future pregnancies, leading to a lowered desire for reversal due to fears of the same outcomes. Additionally, personal, cultural, and sociocultural factors can influence attitudes toward sterilization reversal, with some individuals prioritizing stability and certainty in family planning over potential future pregnancies. Overall, while a history of unintended pregnancy can increase awareness about reproduction, it does not uniformly lessen the desire for sterilization reversal, as individual motivations vary widely based on personal circumstances and experiences.",
        "paper_evidence":
        [
            "Unintended pregnancy has been significantly associated with subsequent female sterilization. Whether women who are sterilized after experiencing an unintended pregnancy are less likely to express desire for sterilization reversal is unknown.",
            "This study used national, cross-sectional data collected by the 2006-2010 National Survey of Family Growth. The study sample included women ages 15-44 who were surgically sterile from a tubal sterilization at the time of interview. Multivariable logistic regression was used to examine the relationship between a history of unintended pregnancy and desire for sterilization reversal while controlling for potential confounders.",
            "In this nationally representative sample of 1,418 women who were sterile from a tubal sterilization, 78% had a history of at least one unintended pregnancy and 28% expressed a desire to have their sterilization reversed. In unadjusted analysis, having a prior unintended pregnancy was associated with higher odds of expressing desire for sterilization reversal (odds ratio [OR]: 1.80; 95% confidence interval [CI]: 1.15-2.79). In adjusted analysis controlling for sociodemographic factors, unintended pregnancy was no longer significantly associated with desire for reversal (OR: 1.46; 95% CI: 0.91-2.34)."
        ]
    },
    "12970636":
    {
        "question": "Does early discharge with nurse home visits affect adequacy of newborn metabolic screening?",
        "llm_evidence": "Early discharge with nurse home visits has been shown to significantly improve the adequacy of newborn metabolic screening. Key insights include:\n\n1. **Enhanced Follow-Up**: Nurse home visits provide targeted education and follow-up care, ensuring that parents understand the importance of newborn screening and the timeline for testing.\n\n2. **Increased Screening Rates**: Studies indicate that newborns discharged early with scheduled home visits are more likely to undergo metabolic screening within the recommended timeframe compared to those who do not receive this support.\n\n3. **Improved Parental Engagement**: The presence of a nurse helps empower parents, leading to higher compliance with screening protocols and timely sample collection.\n\n4. **Reduction in Missed Screenings**: Home visits allow for immediate intervention if a screening is missed or if there are concerns about the baby's health, thus enhancing the overall success rate of newborn screening programs.\n\nIn summary, incorporating nurse home visits after early discharge not only supports families in navigating the healthcare system but actively contributes to the completion and adequacy of newborn metabolic screenings, ultimately improving health outcomes for infants.",
        "paper_evidence":
        [
            "To examine the impact of early discharge on newborn metabolic screening.",
            "Metabolic screening results were obtained from the Alabama State Lab for all infants born at our hospital between 8/1/97, and 1/31/99, and were matched with an existing database of early discharge infants. An early newborn discharge was defined as a discharge between 24 and 47 hours of age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay infants were compared to determine the percentage of newborns screened and the timing of the first adequate specimen.",
            "The state laboratory received specimens from 3860 infants; 1324 were on early discharge newborns and 2536 infants in the traditional stay group. At least one filter paper test (PKU, hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher rate of initial filter paper specimens being inadequate (22.9%) compared with traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat specimens when the initial specimen was inadequate (85.0% early discharge vs 75.3% traditional stay, P=.002). The early discharge group was more likely to have an adequate specimen within the first 9 days of life (1001, 98.8% early discharge vs 2016, 96.7% traditional stay, P=.0005)."
        ]
    },
    "19546588":
    {
        "question": "Does increasing blood pH stimulate protein synthesis in dialysis patients?",
        "llm_evidence": "Increasing blood pH, often achieved through bicarbonate administration in dialysis patients, can enhance protein synthesis. Acid-base imbalances, particularly acidosis, are common in individuals with kidney dysfunction, which can impair protein metabolism and synthesis. Studies indicate that correcting acidosis through increased blood pH promotes an anabolic state, enhances the activity of anabolic hormones, and improves muscle protein synthesis. Additionally, a higher blood pH may reduce catabolic processes that lead to muscle wasting, a frequent concern in dialysis patients. Therefore, maintaining a more alkaline blood pH can be beneficial for protein synthesis in these individuals.",
        "paper_evidence":
        [
            "Although the mechanism of muscle wasting in end-stage renal disease is not fully understood, there is increasing evidence that acidosis induces muscle protein degradation and could therefore contribute to the loss of muscle protein stores of patients on hemodialysis, a prototypical state of chronic metabolic acidosis (CMA). Because body protein mass is controlled by the balance between synthesis and degradation, protein loss can occur as result of either increased breakdown, impaired synthesis, or both. Correction of acidosis may therefore help to maintain muscle mass and improve the health of patients with CMA. We evaluated whether alkalizing patients on hemodialysis might have a positive effect on protein synthesis and on nutritional parameters.",
            "Eight chronic hemodialysis patients were treated daily with oral sodium bicarbonate (NaHCO(3)) supplementation for 10-14 days, yielding a pre-dialytic plasma bicarbonate concentration of 28.6 +/-1.6 mmol/l. The fractional synthesis rates (FSR) of muscle protein and albumin were obtained by the L-[(2)H(5)ring]phenylalanine flooding technique.",
            "Oral NaHCO(3 )supplementation induced a significant increase in serum bicarbonate (21.5 +/- 3.4 vs. 28.6 +/- 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 0.041). The FSR of muscle protein and the FSR of albumin did not change significantly (muscle protein: 2.1 +/- 0.2 vs. 2.0 +/- 0.5% per day, p = 0.39; albumin: 8.3 +/- 2.2 vs. 8.6 +/- 2.5% per day, p = 0.31). Plasma concentrations of insulin-like growth factor 1 decreased significantly (33.4 +/- 21.3 vs. 25.4 +/- 12.3 nmol/l; p = 0.028), whereas thyroid-stimulating hormone, free thyroxin and free triiodothyronine did not change significantly and nutritional parameters showed no improvement."
        ]
    },
    "18616781":
    {
        "question": "Is there a relationship between homocysteine and vitiligo?",
        "llm_evidence": "Homocysteine is an amino acid that, at elevated levels, has been associated with various health conditions, including cardiovascular diseases and neurological disorders. Recent studies suggest that there may be a connection between high homocysteine levels and the autoimmune disorder vitiligo, which is characterized by the loss of skin pigmentation. Elevated homocysteine can lead to oxidative stress and inflammation, both of which are implicated in the pathogenesis of vitiligo. Additionally, deficiencies in vitamins such as B12, B6, and folate, which are essential for homocysteine metabolism, have been observed in some vitiligo patients. Moreover, some research indicates that reducing homocysteine levels through supplementation might have a beneficial impact on the management of vitiligo. Overall, while more research is needed to clarify the extent and mechanisms of this relationship, there is emerging evidence that suggests a link between homocysteine and vitiligo, particularly in its role in inflammation and oxidative damage.",
        "paper_evidence":
        [
            "Pigmentary dilution is observed in patients with homocystinuria. Therefore, it is possible that an increase of local homocysteine (Hcy) interferes with normal melanogenesis and plays a role in the pathogenesis of vitiligo. Vitamin B12 and folic acid, levels of which are decreased in vitiligo, are important cofactors in the metabolism of Hcy. Consequently, a nutritional deficiency in either of these two vitamins will result in an increase in homocysteine in the circulation, a finding that we expect to find in vitiligo.",
            "To determine the level of Hcy in the blood of patients with vitiligo as a first step in revealing if it has any relationship with the pathogenesis of vitiligo and consequently if this will have an impact on the treatment of vitiligo.",
            "Twenty-six patients of both sexes with vitiligo (age range 20-50 years, mean 31.4 +/- 8.09) and 26 age-matched healthy controls were included in the study. After excluding factors that may affect serum Hcy levels, blood samples from patients and controls were obtained for homocysteine determination by enzyme immunoassay.",
            "The mean serum level of Hcy was significantly higher in patients with vitiligo than in controls (21.61 +/- 13.28 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). The Hcy level was significantly higher in male patients than in female patients (28.67 +/- 15.95 vs. 15.56 +/- 6.2 micromol L(-1); P<0.001) and in male controls compared with female controls (15.07 +/- 4.61 vs. 12.05 +/- 4.82 micromol L(-1); P<0.001). The homocysteine level was related to the activity of vitiligo and was significantly higher in patients with progressive disease than in controls (25.4 +/- 14.99 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). No significant difference in Hcy levels was found between either untreated vitiligo patients (22.77 +/- 13.36 micromol L(-1)) or patients receiving ultraviolet therapy (20.45 +/- 13.73 micromol L(-1)) and the total patient group (21.62 +/- 13.28 micromol L(-1))."
        ]
    },
    "16971978":
    {
        "question": "Are complex coronary lesions more frequent in patients with diabetes mellitus?",
        "llm_evidence": "Patients with diabetes mellitus (DM) are indeed more likely to present with complex coronary lesions compared to non-diabetic individuals. Studies have shown that diabetes contributes to accelerated atherosclerosis, leading to the formation of more intricate and advanced coronary artery disease. Key insights include:\n\n1. **Pathophysiological Factors**: Diabetes is associated with hyperglycemia, insulin resistance, and dyslipidemia, which promote vascular inflammation and endothelial dysfunction, accelerating plaque formation and progression.\n\n2. **Angiographic Findings**: Research indicates that diabetic patients often exhibit a higher incidence of multi-vessel disease and more severe stenosis, contributing to complex lesions characterized by calcifications and thrombus formations.\n\n3. **Outcomes**: Diabetic patients are at an increased risk for adverse cardiac events due to the presence of complex lesions, as they tend to present with more extensive heart disease and experience poorer prognoses following interventions like angioplasty or surgery.\n\n4. **Clinical Implications**: Understanding the prevalence of complex coronary lesions in diabetic populations emphasizes the need for vigilant cardiovascular screening and tailored therapeutic approaches for these patients.\n\nThis evidence collectively supports the assertion that complex coronary lesions are indeed more frequent in individuals with diabetes mellitus.",
        "paper_evidence":
        [
            "Coronary atherosclerotic burden is excessive in diabetic patients. Diabetes mellitus (DM) is an independent predictor for both death and myocardial infarction. It is not known whether the prevalence of complex coronary lesions, such as bifurcation and ostial lesions, is different in diabetics from nondiabetics.",
            "The aim of present study was to investigate the prevalence of these lesions in patients with DM.",
            "One thousand fourteen consecutive patients (mean age 61.3+/-10.7 years) were investigated. Coronary angiograms were examined for bifurcation and ostial lesions using a digital quantitative system. Patients were classified as diabetic (n=281) or nondiabetic (n=733).",
            "Patient mean age, and rates of hypertension and hyperlipidemia were significantly higher in the diabetic group than in the nondiabetic group (P<0.0001), although smoking was significantly lower (P=0.001). Reasons for coronary angiography and treatment were comparable between the two groups. The prevalence of bifurcation lesions and ostial lesions was significantly greater in the diabetic group than in the nondiabetic group (9.8% versus 4.3% [P=0.001] and 38.4% versus 29.2% [P=0.003]in the diabetic group versus the nondiabetic group). The presence of DM and greater age were found to be independent predictors for bifurcation lesions (OR=2.27 [P=0.004] and OR=1.03 [P=0.01], for DM and age, respectively) and ostial lesions (OR=1.40 [P=0.027] and OR=1.02 [P=0.001], for DM and age, respectively) in multivariate analysis."
        ]
    },
    "20736887":
    {
        "question": "Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy?",
        "llm_evidence": "Decompressive surgery can be effective for patients with spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly when there is significant spinal cord compression contributing to neurological deficits. Key insights include:\n\n1. **Symptomatic Relief**: Decompressive surgery aims to relieve pressure on the spinal cord and nerve roots. Many patients experience improvement in symptoms such as pain, weakness, and sensory deficits following surgery.\n\n2. **Histopathological Considerations**: Sarcoidosis can cause granulomatous inflammation, leading to spinal cord lesions that may compress neural structures. Surgical intervention can remove obstructive tissue and alleviate compressive effects.\n\n3. **Patient Selection**: Success largely depends on timely intervention and appropriate patient selection. Candidates typically include those with progressive neurological symptoms and confirmed compressive lesions on imaging studies.\n\n4. **Variable Outcomes**: While many patients benefit from decompression, outcomes can vary based on the severity of myelopathy, the duration of symptoms prior to surgery, and pre-existing neurological deficits.\n\n5. **Adjunctive Therapies**: Post-surgical management may include corticosteroids or other immunosuppressive therapies to address the underlying sarcoidosis, potentially enhancing recovery and preventing relapse.\n\nIn conclusion, decompressive surgery may provide significant advantages for select patients suffering from spinal cord sarcoidosis and associated myelopathy, although individual outcomes vary and should be assessed on a case-by-case basis.",
        "paper_evidence":
        [
            "A retrospective multicenter study of series of 12 patients with spinal cord sarcoidosis who underwent surgery.",
            "To evaluate the postoperative outcomes of patients with cervical spinal cord sarcoidosis accompanied with compressive myelopathy and effect of decompressive surgery on the prognosis of sarcoidosis.",
            "Sarcoidosis is a chronic, multisystem noncaseating granulomatous disease. It is difficult to differentiate spinal cord sarcoidosis from cervical compressive myelopathy. There are no studies regarding the coexistence of compressive cervical myelopathy with cervical spinal cord sarcoidosis and the effect of decompressive surgery.",
            "Nagoya Spine Group database included 1560 cases with cervical myelopathy treated with cervical laminectomy or laminoplasty from 2001 to 2005. A total of 12 patients (0.08% of cervical myelopathy) were identified spinal cord sarcoidosis treated with decompressive surgery. As a control subject, 8 patients with spinal cord sarcoidosis without compressive lesion who underwent high-dose steroid therapy without surgery were recruited.",
            "In the surgery group, enhancing lesions on magnetic resonance imaging (MRI) were mostly seen at C5-C6, coincident with the maximum compression level in all cases. Postoperative recovery rates in the surgery group at 1 week and 4 weeks were -7.4% and -1.1%, respectively. Only 5 cases had showed clinical improvement, and the condition of these 5 patients had worsened again at averaged 7.4 weeks after surgery. Postoperative oral steroid therapy was initiated at an average of 6.4 weeks and the average initial dose was 54.0 mg in the surgery group, while 51.3 mg in the nonsurgery group. The recovery rate of the Japanese Orthopedic Association score, which increased after steroid therapy, was better in the nonsurgery group (62.5%) than in the surgery group (18.6%) with significant difference (P<0.01)."
        ]
    },
    "21164063":
    {
        "question": "Is there a role for fondaparinux in perioperative bridging?",
        "llm_evidence": "Fondaparinux is a synthetic anticoagulant that acts as a Factor Xa inhibitor. Its role in perioperative bridging has gained attention due to its pharmacokinetic properties, including a long half-life, predictable dosing, and a low risk of heparin-induced thrombocytopenia. \n\nKey insights supporting its use in perioperative bridging include:\n\n1. **Anticoagulation Efficacy**: Fondaparinux is effective in preventing thromboembolic events in patients at high risk, such as those with a history of venous thromboembolism or atrial fibrillation. This makes it a valuable option for bridging patients when they need to interrupt their direct anticoagulant therapy before surgery.\n\n2. **Safety Profile**: The risk of major bleeding associated with fondaparinux is generally lower compared to traditional anticoagulants like low-molecular-weight heparin (LMWH) or unfractionated heparin, making it a safer choice in the perioperative setting.\n\n3. **Brief Interruption Use**: Fondaparinux is particularly suitable when a brief interruption of anticoagulation is required. Its dosing schedule allows for initiation postoperatively, enabling timely resumption of anticoagulation while managing the surgical risk.\n\n4. **Limited Monitoring Requirement**: Unlike some other anticoagulants, fondaparinux does not require routine monitoring, which simplifies management protocols in the perioperative context.\n\nOverall, while clinical guidelines may vary, evidence suggests that fondaparinux can be an effective option for perioperative bridging, particularly for select patients where traditional bridging therapies may pose higher risks. However, individual patient factors and the type of surgery should always guide the decision-making process.",
        "paper_evidence":
        [
            "A possible role for fondaparinux as a bridging agent in the perioperative setting is explored.",
            "Anticoagulation guidelines provide minimal direction on the perioperative use of fondaparinux. Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before surgery is an issue, particularly in surgeries with a high bleeding risk or in which neuraxial anesthesia is used. Guidance for perioperative bridging with fondaparinux must be derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for venous thromboembolism prophylaxis in surgical patients, and the majority avoided its use before surgery in patients receiving neuraxial anesthesia. Three case reports cited the use of fondaparinux sodium as perioperative bridge therapy; one used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. Furthermore, professional anesthesia guidelines conflict in their recommendations regarding the timing of drug administration with neuraxial catheter use. For these reasons, it may be optimal to avoid fondaparinux use before surgery. In some instances, the use of low-molecular-weight heparin or inpatient use of i.v. unfractionated heparin is not possible, is contraindicated, or has limited efficacy, such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients."
        ]
    },
    "15488260":
    {
        "question": "Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?",
        "llm_evidence": "Yes, the type of remission after a major depressive episode is an important risk factor for relapses in a 4-year follow-up. Research indicates that individuals who experience partial remission, characterized by lingering symptoms, are at a higher risk for recurrence compared to those achieving full remission, where symptoms are significantly reduced or absent. Studies have shown that the nature of the remissionâ€”whether it is full, partial, or characterized by residual symptomsâ€”affects the likelihood of subsequent depressive episodes. Additionally, factors such as the duration of the remission and the presence of comorbid conditions also contribute to relapse risk. Therefore, understanding the nuances of remission types can be crucial for developing tailored treatment strategies aimed at minimizing relapse rates in patients recovering from major depressive disorder (MDD).",
        "paper_evidence":
        [
            "Rates of relapse and predictive relapse factors were studied over more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for unipolar major depressive episode.",
            "A final sample of 139 outpatient was followed monthly in a naturalistic study. The Structured Clinical Interview for DSM-III-R was used. Phases of evolution were recorded using the Hamilton Depression Rating Scale, applying the Frank criteria. Survival analysis, Kaplan-Meier product limit and proportional hazards models were used.",
            "A higher rate of relapses was observed in the partial remission group (91.4%) compared to the complete remission one (51.3%). The four factors with predictive relapse value were: \"partial remission versus complete remission\", \"the intensity of clinical symptoms\", \"the age\" and \"the number of previous depressive episodes\". The existence of partial remission was the most powerful predictive factor.",
            "The decreasing sample size during the follow-up and the difficulty in warranting the treatment compliance."
        ]
    },
    "19481382":
    {
        "question": "Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?",
        "llm_evidence": "The Androgen Deficiency of Aging Men (ADAM) questionnaire is a tool designed to help identify men who may be experiencing symptoms of low testosterone levels, commonly referred to as androgen deficiency. Research indicates that the ADAM questionnaire is useful as a preliminary screening tool for partial androgen deficiency in aging men. Key insights supporting its utility include:\n\n1. **Symptom Identification**: The ADAM questionnaire focuses on specific symptoms commonly associated with androgen deficiency, such as decreased libido, fatigue, and mood changes, making it effective for identifying individuals who may require further evaluation.\n\n2. **Validation Studies**: Multiple validation studies have demonstrated that the ADAM questionnaire has a reasonable sensitivity and specificity for detecting low testosterone levels, which supports its use as a screening measure in clinical settings.\n\n3. **Ease of Use**: The questionnaire's straightforward format allows for quick administration and self-assessment, facilitating its adoption in various healthcare environments.\n\n4. **Guidance for Further Testing**: While the ADAM questionnaire is not a definitive diagnostic tool, it serves as a valuable first step that can prompt clinicians to conduct more comprehensive hormonal assessments in men who present with compatible symptoms.\n\nIn summary, the ADAM questionnaire can be considered a useful screening instrument for identifying potential cases of partial androgen deficiency among aging men, guiding the need for further diagnostic evaluation.",
        "paper_evidence":
        [
            "Androgen serum levels significantly decrease in older men, causing quality of life impairment and increasing the risk of chronic disease. This disorder is defined as PADAM (Partial Androgen Deficiency of Aging Men).",
            "To evaluate a PADAM screening tool and determine the prevalence of this disorder in healthy adult men.",
            "This was a cross-sectional study in which 96 men aged 40 or more of the South Metropolitan Region of Santiago de Chile were surveyed with the Androgen Deficiency of Aging Men (ADAM) questionnaire of the Saint Louis University and sampled for the serum determination of total testosterone, sexual hormone binding globulin (SHBG) and albumin. Also free and bioavailable testosterone were calculated. PADAM was considered present if items 1 or 7 or any 3 other questions of the ADAM questionnaire were positive. An available testosterone of<198.4 ng/dL was used as a gold standard for the diagnosis of PADAM.",
            "A total of 78 men (81.3%) were identified as possible PADAM according to the ADAM questionnaire. Total testosterone levels fell from 503.6+/-180.1 ng/dL in men aged 40 to 54 years to 382.1+/-247.3 in those>70 years; however this was not statistically significant (ANOVA, p=0.06). In the same age groups, SHBG significantly increased (31.0+/-15.0 to 47.5+/-15.0 nmol/L, p<0.001) whereas free and available testosterone significantly decreased (10.6+/-3.2 to 6.4+/-3.6 ng/dL and 266.6+/-81.2 to 152.2+/-97.6 ng/dL, respectively, p<0.0001). Overall (n=96), available testosterone confirmed PADAM diagnosis in 27 cases (28.1%). The ADAM tool rendered a 83.3% sensitivity and 19.7% specificity in the detection of PADAM. Item 1 (decreased sexual desire) was a better predictor of hypogonadism than the complete questionnaire (63.3% sensitivity and 66.7% specificity)."
        ]
    },
    "25699562":
    {
        "question": "Does the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?",
        "llm_evidence": "The Transmissible Liability Index (TLI) is designed to evaluate the genetic and environmental influences that predispose individuals to mental health issues, including suicidal tendencies. Research indicates that higher TLI scores in late childhood correlate with increased risk factors for mental health disorders in young adulthood, including suicidal symptoms. Key studies have shown that children with elevated TLI assessments often experience heightened emotional distress and dysfunctional coping mechanisms as they mature. Additionally, longitudinal analyses suggest that those identified with a higher TLI during childhood display greater prevalence of psychiatric conditions that are associated with suicidal ideation and behavior in young adulthood. As a result, the TLI serves as a predictive marker for identifying individuals who may be at greater risk for suicide in later years, highlighting the importance of early intervention and monitoring.",
        "paper_evidence":
        [
            "Our previous work demonstrated that the Transmissible Liability Index (TLI), an instrument designed as an index of liability for substance use disorder (SUD), is associated with risk of substance use disorder. This longitudinal study assessed whether TLI measured in 10-12-year-olds (late childhood) predicts suicidal behavior from age 12-14 (preadolescence) to age 25 (young adulthood). We hypothesized that TLI would predict number and severity of suicide attempts.",
            "Subjects were sons of men who had lifetime history of SUD (nâ€‰=â€‰250), called the High Average Risk (HAR) group, and sons of men with no lifetime history of a SUD (nâ€‰=â€‰250), called the Low Average Risk (LAR) group. The TLI was delineated at baseline (age 10-12), and age-specific versions were administered at 12-14, 16, 19, 22, and 25 years of age.",
            "TLI was significantly associated with number and severity of lifetime suicide attempts."
        ]
    },
    "20971618":
    {
        "question": "Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?",
        "llm_evidence": "Research has indicated that children with atopic dermatitis (AD) have a higher risk of developing secondary infections, including impetigo, molluscum contagiosum, and herpes infections. The compromised skin barrier associated with AD allows pathogens easier access to the skin, leading to increased susceptibility. \n\n1. **Impetigo**: Studies show that children with AD are more prone to bacterial superinfections, notably impetigo, due to scratching and skin barrier disruptions. The prevalence of impetigo in children with AD can be significantly higher compared to those without.\n\n2. **Molluscum contagiosum**: Molluscum contagiosum, a viral skin infection, has also been found to be more prevalent in children with AD. The inflammatory skin condition can create an environment conducive to viral infections.\n\n3. **Herpes infections**: Children with AD are more likely to experience herpes simplex infections, particularly eczema herpeticum, which can occur when the herpes virus infects skin affected by atopic dermatitis. This can lead to severe outbreaks compared to children without AD.\n\nIn conclusion, the evidence supports that the lifetime prevalence of impetigo, molluscum, and herpes infections is indeed increased in children who have atopic dermatitis due to the underlying skin barrier dysfunction and the heightened risk of skin injury and infection.",
        "paper_evidence":
        [
            "Cutaneous infections such as impetigo contagiosum (IC), molluscum contagiosum (MC) and herpes virus infection (HI) appear to be associated with atopic dermatitis (AD), but there are no reports of concrete epidemiological evidence.",
            "We evaluated the association of childhood AD with these infections by conducting a population-based cross-sectional study.",
            "Enrolled in this study were 1117 children aged 0-6 years old attending nursery schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was performed by dermatologists, and a questionnaire was completed on each child's history of allergic diseases including AD, asthma, allergic rhinitis and egg allergy, and that of skin infections including IC, MC and HI, as well as familial history of AD.",
            "In 913 children (AD; 132), a history of IC, MC or HI was observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression analysis revealed that the odds of having a history of IC were 1.8 times higher in AD children than in non-AD children. Meanwhile, a history of MC was significantly correlated to the male gender, but not to a personal history of AD. As for HI, we found no correlated factors in this study."
        ]
    },
    "21849531":
    {
        "question": "Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?",
        "llm_evidence": "Growth hormone replacement therapy (GHRT) has been shown to have several beneficial effects in adults with growth hormone deficiency (GHD), including improvements in body composition, metabolism, and quality of life. Studies indicate that GHRT can lead to reductions in body fat, increases in lean muscle mass, and enhancements in physical performance, which are critical factors in overall health.\n\nKey insights from clinical research suggest that GHD is associated with an increased risk of cardiovascular diseases and metabolic disorders, which can contribute to higher mortality rates. By addressing these underlying issues, GHRT may reduce the risk of such complications. Some observational studies indicate that patients receiving GHRT have a lower mortality risk compared to untreated individuals with GHD. \n\nHowever, while the therapy appears to have life-quality improvements and potential mortality benefits, the evidence is not uniformly conclusive. Further long-term, randomized controlled trials are needed to definitively establish the effect of GHRT on mortality rates in this population. Overall, GHRT can improve health outcomes in adults with GHD, contributing positively to factors that may lower mortality risk.",
        "paper_evidence":
        [
            "Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established.",
            "This nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults.",
            "Patients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups.",
            "Standardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts.",
            "In the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors."
        ]
    },
    "10173769":
    {
        "question": "Longer term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?",
        "llm_evidence": "The Barthel Index is a widely used tool for assessing the functional independence of stroke patients, focusing on activities of daily living (ADLs). However, relying solely on the Barthel Index may not provide a comprehensive view of long-term quality of life and outcomes for stroke survivors. \n\nKey insights include:\n\n1. **Multidimensional Factors**: Quality of life after a stroke is influenced by physical, emotional, and social aspects. While the Barthel Index measures physical function, it does not capture psychological well-being, cognitive function, social participation, or overall quality of life.\n\n2. **Complementary Assessments**: Studies suggest that combining the Barthel Index with other assessments, such as the Modified Rankin Scale (mRS) for overall disability, the National Institutes of Health Stroke Scale (NIHSS) for acute stroke severity, and quality of life measures like the EQ-5D, can provide a more holistic evaluation of patient outcomes.\n\n3. **Variability in Recovery**: Stroke recovery can vary significantly among individuals, and factors such as age, comorbidities, and support systems play a crucial role. Relying solely on the Barthel Index may overlook important determinants of long-term success and rehabilitation needs.\n\n4. **Functional vs. Quality of Life**: While a patient may achieve a high Barthel Index score indicating independence in ADLs, they may still have a poor quality of life due to depression, anxiety, or other psychosocial issues.\n\nIn conclusion, while the Barthel Index is a valuable tool for measuring functional recovery, it should be part of a broader battery of assessments to adequately capture the long-term quality of life and outcomes in stroke patients.",
        "paper_evidence":
        [
            "To consider whether the Barthel Index alone provides sufficient information about the long term outcome of stroke.",
            "Cross sectional follow up study with a structured interview questionnaire and measures of impairment, disability, handicap, and general health. The scales used were the hospital anxiety and depression scale, mini mental state examination, Barthel index, modified Rankin scale, London handicap scale, Frenchay activities index, SF36, Nottingham health profile, life satisfaction index, and the caregiver strain index.",
            "South east London.",
            "People, and their identified carers, resident in south east London in 1989-90 when they had their first in a life-time stroke aged under 75 years.",
            "Observational study.",
            "Comparison and correlation of the individual Barthel index scores with the scores on other outcome measures.",
            "One hundred and twenty three (42%) people were known to be alive, of whom 106 (86%) were interviewed. The median age was 71 years (range 34-79). The mean interval between the stroke and follow up was 4.9 years. The rank correlation coefficients between the Barthel and the different dimensions of the SF36 ranged from r = 0.217 (with the role emotional dimension) to r = 0.810 (with the physical functioning dimension); with the Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) to r = -0.840 (with the physical mobility dimension); with the hospital and anxiety scale depression component the coefficient was r = -0.563, with the life satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with the Frenchay activities index r = 0.826."
        ]
    },
    "14968373":
    {
        "question": "Can CT predict the level of CSF block in tuberculous hydrocephalus?",
        "llm_evidence": "CT imaging is a vital tool in the evaluation of tuberculous hydrocephalus, as it can reveal characteristic features of the condition. Key insights include:\n\n1. **Ventricular Enlargement**: CT scans typically show marked enlargement of the lateral and third ventricles due to blocked cerebrospinal fluid (CSF) pathways resulting from tuberculous infiltrates or abscesses.\n\n2. **Basal Meningeal Enhancement**: Enhanced basal meninges on CT can indicate the presence of inflammatory changes that often accompany tuberculous infection, which can help predict the site of CSF obstruction.\n\n3. **Obstruction Sites**: The location of the obstruction can often be inferred from the pattern of ventricular enlargement and the presence of accompanying lesions, suggesting whether the block is at the level of the foramen of Monro, aqueduct of Sylvius, or other CSF pathways.\n\n4. **Cornual Compression**: The presence of tuberculomas or other mass effects compressing specific ventricle parts can provide insights into potential levels of blockage in the CSF drainage system.\n\nThrough detailed CT analysis, clinicians can develop a more informed understanding of the extent and location of CSF block in patients with tuberculous hydrocephalus, aiding in treatment planning and prognosis.",
        "paper_evidence":
        [
            "Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cranial computerised tomography (CT).",
            "A number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings.",
            "The only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus."
        ]
    },
    "24591144":
    {
        "question": "Are the elderly with oropharyngeal carcinoma undertreated?",
        "llm_evidence": "Elderly patients with oropharyngeal carcinoma are often undertreated due to several factors. Research indicates that this demographic frequently faces barriers to receiving optimal treatment, including comorbidities, age-related concerns about treatment tolerance, and biases in treatment decision-making. Studies show that elderly patients with aggressive cancers, such as oropharyngeal carcinoma, are less likely to receive guideline-concordant therapies, including surgery, chemotherapy, or radiotherapy. Additionally, there is a tendency among healthcare providers to recommend less aggressive treatments based on misconceptions about the general health status and life expectancy of elderly patients. This undertreatment can lead to poorer outcomes, highlighting a critical need for re-evaluating treatment protocols and advocating for more individualized care approaches for elderly patients.",
        "paper_evidence":
        [
            "To determine if elderly patients with oropharyngeal squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the benefit of aggressive therapy in this population.",
            "Retrospective analysis of a large population database.",
            "Patients in the Surveillance, Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 were included. The patients were categorized into age groups 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage (III and IV) OPSCC was performed for all age and treatment categories, followed by a multivariate cox regression of treatment status, tumor site, race, stage, and sex per age group.",
            "A total of 14,909 patients with OPSCC were identified. In our demographic data, we observed a significant increase in the number of patients who did not receive treatment (surgery, radiation, or combined therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 75 to 84 had substantial benefits in DSS with surgery, radiation, or combined therapy. Multivariable analysis did not demonstrate any statistically significant difference in the hazard ratios for combined treatment among age groups 45 to 54, 55 to 64, 65 to 74, and 75 to 84."
        ]
    },
    "21431987":
    {
        "question": "Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?",
        "llm_evidence": "Preoperative staging of patients with liver metastases from colorectal carcinoma is crucial for treatment planning and prognostic assessment. Multidetector CT (MDCT) remains the standard imaging modality due to its high spatial resolution and ability to detect liver lesions. However, PET/CT combines metabolic and anatomic imaging, which can enhance the detection of metabolic activity in lesions that may be missed on MDCT alone.\n\nKey insights include:\n\n1. **Detection of Additional Metastases**: Studies indicate that PET/CT can identify additional metastatic sites, particularly in cases of occult disease that MDCT may not detect, thus altering the management plan.\n\n2. **Evaluation of Non-viable Lesions**: PET/CT may provide insight into the viability of lesions, helping distinguish between active tumor and scar tissue, which can influence surgical decisions.\n\n3. **Impact on Surgical Outcomes**: Some research suggests that incorporating PET/CT into preoperative assessment can improve surgical outcomes by providing a more accurate staging, thereby guiding appropriate surgical intervention.\n\n4. **Cost-effectiveness**: While PET/CT has advantages, its cost and availability compared to MDCT could influence its use, prompting practices to consider patient selection carefully.\n\nIn conclusion, while MDCT is a foundational imaging tool in preoperative staging, PET/CT can add significant value by identifying additional metastases, assessing lesion viability, and ultimately influencing treatment decisions, although its role must be weighed against cost and accessibility in clinical practice.",
        "paper_evidence":
        [
            "This study was designed to determine prospectively whether the systematic use of PET/CT associated with conventional techniques could improve the accuracy of staging in patients with liver metastases of colorectal carcinoma. We also assessed the impact on the therapeutic strategy.",
            "Between 2006 and 2008, 97 patients who were evaluated for resection of LMCRC were prospectively enrolled. Preoperative workup included multidetector-CT (MDCT) and PET/CT. In 11 patients with liver steatosis or iodinated contrast allergy, MR also was performed. Sixty-eight patients underwent laparotomy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values for hepatic and extrahepatic staging of MDCT and PET-CT were calculated.",
            "In a lesion-by-lesion analysis of the hepatic staging, the sensitivity of MDCT/RM was superior to PET/CT (89.2 vs. 55%, pÂ <Â 0.001). On the extrahepatic staging, PET/CT was superior to MDCT/MR only for the detection of locoregional recurrence (pÂ =Â 0.03) and recurrence in uncommon sites (pÂ =Â 0.016). New findings in PET/CT resulted in a change in therapeutic strategy in 17 patients. However, additional information was correct only in eight cases and wrong in nine patients."
        ]
    },
    "18319270":
    {
        "question": "Does confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?",
        "llm_evidence": "Confined placental mosaicism (CPM) involves the presence of two or more genetically distinct cell lines within the placenta, which can arise during early embryonic development. Research indicates that CPM is more prevalent in in vitro fertilization (IVF) pregnancies compared to naturally conceived pregnancies. Studies have shown that CPM can be associated with several adverse perinatal outcomes, such as increased risks of preterm birth, fetal growth restriction, and placental abruption. \n\nKey insights include:\n\n1. **Increased Prevalence in IVF**: IVF pregnancies display higher instances of CPM, suggesting that the assisted reproductive technologies may influence its occurrence.\n\n2. **Clinical Impacts**: Evidence indicates that pregnancies affected by CPM can lead to complications due to abnormal placental function, potentially impacting the delivery of nutrients and oxygen to the fetus.\n\n3. **Histopathological Findings**: Analysis of placentas with CPM often reveals placental insufficiency, correlating with poorer neonatal outcomes, highlighting the significant impact of placental health on perinatal well-being.\n\nOverall, the connection between confined placental mosaicism and adverse perinatal outcomes in IVF pregnancies underscores the need for careful monitoring and evaluation of placental health in this population.",
        "paper_evidence":
        [
            "IVF singletons have poorer perinatal outcomes than singletons from spontaneous conceptions. This may be due to the influence of ovarian stimulation on the chromosomal constitution of the embryos which could be translated into localized chromosomal anomalies in the placenta. The aim of this study was to compare the incidence of confined placental mosaicism (CPM) in IVF/ICSI pregnancies and spontaneous conceptions.",
            "We conducted a multi-centre retrospective analysis of karyotype results obtained by chorionic villus sampling (CVS), performed due to advanced maternal age (>or=36 years at 18 weeks of gestation), in the Netherlands between 1995 and 2005.",
            "From a total of 322 246 pregnancies, 20 885 CVS results were analysed: 235 in the IVF/ICSI group and 20 650 in the control group. The mean age of women in both groups was 38.4 years (mean difference -0.08, 95% CI -0.35 to 0.18). Data relating to the fetal karyotype were missing in 143 cases in the control group. When taking into account missing data, the incidence of CPM was lower in the IVF-ICSI group than in the control group, 1.3% versus 2.2% (odds ratio 0.59, 95% CI 0.19-1.85), whereas the incidence of fetal chromosomal anomalies was increased 4.3% versus 2.4% (odds ratio 1.81, 95% CI 0.95-3.42). Neither differences were statistically significant."
        ]
    },
    "23736032":
    {
        "question": "Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?",
        "llm_evidence": "In the management of breast cancer, multidisciplinary teams (MDTs) typically consist of oncologists, surgeons, radiologists, and other specialists who collaborate to develop a comprehensive treatment plan tailored to each patientâ€™s unique circumstances. Research indicates that while MDT recommendations often include surgery, chemotherapy, and radiation, there is variability in how closely these recommendations are followed by patients. Factors influencing adherence to MDT recommendations include:\n\n1. **Patient Understanding**: Effective communication between the MDT and the patient is crucial. Patients who fully understand the reasoning behind their recommended treatment are more likely to adhere to it.\n\n2. **Socioeconomic Factors**: Access to care, financial resources, and support systems significantly affect a patient's ability to follow through with recommended interventions.\n\n3. **Psychosocial Influences**: Emotional well-being and support from family and friends can play a vital role in a patient's decision-making process regarding treatment adherence.\n\n4. **Treatment Beliefs**: Patients' personal beliefs about the effectiveness and side effects of the recommended therapies can lead to treatment acceptance or refusal.\n\n5. **Integrated Care Models**: Stronger integration of care, wherein patients are closely monitored by their MDT throughout the treatment journey, has been found to increase adherence rates.\n\nEvidence suggests that while MDTs provide well-informed recommendations, patient adherence varies, necessitating a focus on patient education, support, and individualized care approaches to enhance compliance with recommended treatments.",
        "paper_evidence":
        [
            "A multidisciplinary team (MDT) approach to breast cancer management is the gold standard. The aim is to evaluate MDT decision making in a modern breast unit.",
            "All referrals to the breast MDT where breast cancer was diagnosed from 1 July 2009 to 30 June 2011 were included. Multidisciplinary team decisions were compared with subsequent patient management and classified as concordant or discordant.",
            "Over the study period, there were 3230 MDT decisions relating to 705 patients. Overall, 91.5% (2956 out of 3230) of decisions were concordant, 4.5% (146 out of 3230), were discordant and 4% (128 out of 3230) had no MDT decision. Of 146 discordant decisions, 26 (17.8%) were considered 'unjustifiable' as there was no additional information available after the MDT to account for the change in management. The remaining 120 discordant MDT decisions were considered 'justifiable', as management was altered due to patient choice (n=61), additional information available after MDT (n=54) or MDT error (n=5)."
        ]
    },
    "15053041":
    {
        "question": "Do acute changes in heart rate by isoproterenol affect aortic stiffness in patients with hypertension?",
        "llm_evidence": "Isoproterenol, a non-selective beta-adrenergic agonist, is known to induce acute increases in heart rate. In patients with hypertension, studies suggest that these changes can significantly impact aortic stiffness, a key factor in cardiovascular health. \n\nResearch indicates that increased heart rate can lead to alterations in hemodynamic parameters, which may exacerbate aortic stiffness. The mechanism involves enhanced pulsatile load on the arterial wall, resulting in structural changes over time. Additionally, isoproterenol's influence on vascular smooth muscle tone and endothelial function contributes to this relationship. \n\nClinical observations show that patients with hypertension often exhibit increased aortic stiffness, which is linked to adverse cardiovascular outcomes. The acute rise in heart rate induced by isoproterenol can transiently elevate aortic pressure and stress, further compromising arterial compliance. \n\nThus, the acute changes in heart rate from isoproterenol appear to have a direct association with increased aortic stiffness in hypertensive patients, highlighting the importance of heart rate management in this population.",
        "paper_evidence":
        [
            "Increased aortic stiffness is a independent risk factor of cardiovascular disease in patients with hypertension. Acute changes of the heart rate (HR) have been reported not to affect the aortic stiffness in pacing. However, it is unknown whether acute changes in HR caused by sympathomimetics can affect the aortic stiffness in patients with hypertension. We investigated the effect of acute changes in HR produced by isoproterenol on the aortic stiffness in 17 hypertensive patientss (mean age: 59 +/- 9 years).",
            "All vasoactive drugs were discontinued at least 3 days before the study. The carotid-to-femoral pulse wave velocity (PWV) was measured by the foot-to-foot method. The pulse waves were recorded at the baseline and at every increase of HR by 5 to 10 bpm with a gradual increase of the dose of isoproterenol. The blood pressures and HR were measured simultaneously. For the analysis, HR, PWV, compliance (C), and compliance index (Ci) were converted as percent changes (delta) from the baseline values. Percent changes of the parameters of the aortic stiffness, i.e., deltaPWV, deltaC, and deltaCi, were grouped by every 10% increase in deltaHR.",
            "There was no significant difference among groups in deltaPWV, deltaC and deltaCi (p>0.05 for each of the group). The regression analysis showed no significant correlation of deltaHR with deltaPWV and deltaC (r = 0.18, 0.13 respectively, p>0.05 for each). deltaCi had a poor correlation with deltaHR (r = 0.22, p<0.05). However, only 4.6% of deltaCi could be referred to deltaHR (r2 = 0.046)."
        ]
    },
    "24340838":
    {
        "question": "Do ventricular arrhythmias in athletes subside over time?",
        "llm_evidence": "Ventricular arrhythmias in athletes can vary in their clinical course, but several studies suggest that they may subside over time in certain populations. Key insights include:\n\n1. **Physiological Adaptation**: In well-trained athletes, chronic adaptations to exercise, such as enhanced autonomic regulation and cardiac remodeling, may lead to a reduction in the frequency and severity of arrhythmias as the athlete continues training.\n\n2. **Young Age Factor**: Many athletes presenting with benign ventricular arrhythmias, particularly in a younger demographic, often experience a natural resolution of symptoms as their cardiovascular system continues to adapt to exercise over the years.\n\n3. **Follow-up Studies**: Research indicated that athletes diagnosed with ventricular ectopy during their young athletic careers showed a significant decrease in arrhythmia episodes upon follow-up evaluations, particularly when re-evaluated years later without any significant cardiovascular pathology.\n\n4. **Potential for Misdiagnosis**: Some arrhythmias observed in athletes may be transient and related to training effects or physiological stress, rather than indicative of underlying heart disease, leading to a decrease in symptoms over time.\n\nIn conclusion, while individual outcomes may vary, there is considerable evidence suggesting that ventricular arrhythmias in athletes can subside or significantly improve as a result of ongoing training and physiological adaptations.",
        "paper_evidence":
        [
            "Sudden death in athletes can occur during sport activities and is presumably related to ventricular arrhythmias.",
            "To investigate the long-term follow-up ofathletes with ventricular arrhythmias during an exercise test.",
            "From a database of 56,462 athletes we identified 192 athletes (35 years old who had ventricular arrhythmias during an exercise test. Ninety athletes had>or =3 ventricular premature beats (VPB) (group A) and 102 athletes had ventricular couplets or non-sustained ventricular tachycardia during an exercise test (group B). A control group of 92 athletesfrom without ventricular arrhythmias was randomly seleclted from the database (group C). Of the 192 athletes 39 returnied for a repeat exercise test after a mean follow-up period of 70 +/- 25 months and they constitute the study population.",
            "Twelve athletes from group A, 21 fromgroup B and 6 from group C returned for a repeat exercise test. The athletes reached a significantly lower peak heart rate during their follow-up exercise test (P = 0.001). More athletes were engaged in competitive sports during their initialexercise test than in the follow-up test (P = 0.021). Most of theathletes who had VPB and/orventricular couplets and/or NSVT during their initial exercise test had far fewer ventricular arrhythmias in the follow-up exercise test (P = 0.001)."
        ]
    },
    "15208005":
    {
        "question": "The Omega-3 Index: a new risk factor for death from coronary heart disease?",
        "llm_evidence": "The Omega-3 Index measures the amount of omega-3 fatty acids (EPA and DHA) in red blood cell membranes. Research indicates that a higher Omega-3 Index is associated with a reduced risk of death from coronary heart disease (CHD). Key insights include:\n\n1. **Epidemiological Studies**: Numerous studies have shown a correlation between higher omega-3 levels and lower rates of mortality from cardiovascular disease, particularly in populations with high fish consumption.\n\n2. **Mechanisms of Action**: Omega-3 fatty acids exhibit anti-inflammatory properties, lower triglyceride levels, and improve endothelial function, all of which contribute to heart health and may reduce the risk of cardiac events.\n\n3. **Clinical Trials**: Randomized controlled trials have demonstrated that omega-3 supplementation can lead to significant reductions in arrhythmias and improve overall cardiovascular outcomes.\n\n4. **Guidelines and Recommendations**: Health organizations increasingly advocate for the inclusion of omega-3 fatty acids in dietary recommendations to promote heart health and potentially lower the risk of coronary heart disease.\n\nOverall, the Omega-3 Index serves as a new risk factor for CHD, where higher levels are linked to improved cardiovascular outcomes and lower mortality rates.",
        "paper_evidence":
        [
            "Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD.",
            "We conducted clinical and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies.",
            "The Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least."
        ]
    },
    "24669960":
    {
        "question": "Does the sex of acute stroke patients influence the effectiveness of rt-PA?",
        "llm_evidence": "Research indicates that the sex of acute stroke patients may influence the effectiveness of recombinant tissue plasminogen activator (rt-PA) therapy. Several studies have shown that female patients tend to have worse outcomes after rt-PA treatment compared to male patients. One potential explanation is that women generally present with a higher median age and more severe strokes, which could affect response to treatment. Additionally, hormonal differences and comorbidities may play a role in how males and females respond to rt-PA, with evidence suggesting that men benefit more significantly from therapy in terms of functional recovery. However, it's important to note that other factors, such as the type of stroke and treatment timing, also critically affect the outcomes and should be considered when evaluating the influence of sex on rt-PA efficacy. Overall, while sex can be a factor in stroke treatment outcomes, further research is necessary to fully understand the complex interactions at play.",
        "paper_evidence":
        [
            "Women have been reported to show more frequent recanalization and better recovery after intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment for acute stroke compared with men. To investigate this we studied a series of stroke patients receiving IV rt-PA and undergoing acute transcranial doppler (TCD) examination.",
            "Acute stroke patients received IV rt-PA and had acute TCD examination within 4 hours of symptom onset at 4 major stroke centers. TCD findings were interpreted using the Thrombolysis in Brain Ischemia (TIBI) flow grading system. The recanalization rates, and poor 3-month outcomes (modified Rankin scale>2) of men and women were compared using the chi-square test. Multiple regression analysis was used to assess sex as a predictor of recanalization and poor 3-month outcome after controlling for age, baseline NIH Stroke Scale (NIHSS), time to treatment, hypertension, and blood glucose.",
            "369 patients had TCD examinations before or during IV rt-PA treatment. The 199 (53.9%) men and 170 (46.1%) women had mean ages of 67â€‰Â±â€‰13 and 70â€‰Â±â€‰14 years, respectively. The sexes did not differ significantly in baseline stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 (34.2%) had complete recanalization, 58 (29.1%) had partial recanalization, and 73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no recanalization (pâ€‰=â€‰0.6). Multiple regression analyses showed no difference between the sexes in recanalization rate, time to recanalization, or clinical outcome at 3 months."
        ]
    },
    "24671913":
    {
        "question": "Does SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?",
        "llm_evidence": "The SYNTAX score, which quantifies the complexity of coronary artery disease, has been shown to be a valuable tool in predicting outcomes in various cardiovascular conditions, including ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Studies indicate that a higher SYNTAX score correlates with increased rates of adverse in-hospital outcomes, such as mortality, major adverse cardiovascular events, and complications related to the procedure. \n\nKey insights include:\n\n1. **Complexity of Disease**: The SYNTAX score assesses both the lesion complexity and the extent of coronary artery disease, providing a comprehensive risk stratification at the time of intervention.\n\n2. **Prognostic Value**: Research has demonstrated that patients with high SYNTAX scores are at a greater risk of in-hospital mortality and complications during and after PCI, compared to those with lower scores.\n\n3. **Clinical Decision-Making**: Incorporating the SYNTAX score into clinical practice helps in stratifying patients based on risk, allowing for tailored approaches to management and intervention strategies.\n\nOverall, the SYNTAX score serves as a useful prognostic tool in predicting adverse in-hospital outcomes in STEMI patients receiving primary PCI, guiding clinicians in risk assessment and management.",
        "paper_evidence":
        [
            "SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI).",
            "The study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital.",
            "The high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 Â± 7.5% and 44.6 Â± 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001)."
        ]
    },
    "17054994":
    {
        "question": "Does frozen section alter surgical management of multinodular thyroid disease?",
        "llm_evidence": "Frozen section analysis during surgery for multinodular thyroid disease can significantly alter surgical management. Key insights include:\n\n1. **Intraoperative Diagnosis**: Frozen sections provide real-time pathological diagnoses, allowing surgeons to determine whether the nodules are benign or malignant during the procedure. This immediate feedback can lead to more informed decisions about the extent of surgery needed.\n\n2. **Reduction in Unnecessary Procedures**: When benign lesions are confirmed via frozen section, surgeons can limit the extent of resection, potentially avoiding unnecessary total thyroidectomies and associated complications, while focusing on more conservative approaches.\n\n3. **Improved Surgical Decision-Making**: Frozen sections can help differentiate between types of thyroid diseases (e.g., differentiated thyroid cancers versus benign adenomas), which aids in tailoring surgical management based on the patient's specific pathology.\n\n4. **Impact on Postoperative Outcomes**: Studies have suggested that the use of frozen section during surgery is associated with lower rates of postoperative complications, shorter recovery times, and better long-term outcomes along with reducing the need for reoperations.\n\nOverall, frozen section analysis has proven to be a valuable tool in the surgical management of multinodular thyroid disease by enhancing decision-making and optimizing patient care.",
        "paper_evidence":
        [
            "Frozen section (FS) evaluation during thyroid surgery is often used to guide intraoperative management. We sought to determine the utility of FS in patients undergoing thyroidectomy for multinodular thyroid disease.",
            "From May 1994 through November 2004, 236 patients with multinodular goiter underwent thyroidectomy at our institution. Patient data were retrospectively analyzed to see if a frozen section was performed during the procedure and whether it changed the patient's outcome.",
            "Of the 236 patients, 135 (57%) had intra-operative FS. There were no differences between patients who had FS analysis and those who did not with regard to age, gender, and the incidence of malignancy. Of the patients who had FS, 4/135 (3%) were subsequently diagnosed with thyroid cancer on permanent histology. Three of these FS were misread as benign. Therefore, the sensitivity of FS for the diagnosis of thyroid cancer was only 25%. Importantly, in none of the 135 patients did FS alter the intraoperative management."
        ]
    },
    "18570208":
    {
        "question": "Is severe macrosomia manifested at 11-14 weeks of gestation?",
        "llm_evidence": "Severe macrosomia, defined as a birth weight greater than 4,000 grams (approximately 8 pounds, 13 ounces), typically develops in the later stages of pregnancy rather than at 11-14 weeks of gestation. At this early stage, fetal growth is still in its infancy, and factors that contribute to macrosomia, such as maternal diabetes, obesity, or gestational weight gain, may not yet be influential enough to result in excessively large fetal size. During the first trimester, fetal measurements are not reliably indicative of macrosomia, as the variability in growth rates is considerable. Instead, macrosomia is generally assessed through ultrasound measurements taken in the second and third trimesters when more accurate estimations of fetal size can be determined. Therefore, severe macrosomia is not typically manifested or diagnosable at the 11-14 week mark of gestation.",
        "paper_evidence":
        [
            "To determine the association between fetal biometry in the first or early second trimester and severe macrosomia at delivery.",
            "This case-control study included 30 term severely macrosomic neonates; 90 appropriate-for-gestational age (AGA) neonates served as controls. All pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' gestation. Pregnancies were dated by accurate last menstrual period consistent with crown-rump length (CRL) measurements at the time of screening, early pregnancy CRL or date of fertilization. The association between birth weight and the difference between the measured and the expected CRL at the time of NT screening was analyzed.",
            "The difference between measured and expected CRL, expressed both in mm and in days of gestation, was statistically greater in the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm vs. 1.17 +/- 4.6 mm, P<0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P<0.0001, respectively). Furthermore, there were significant correlations between the extent of macrosomia and the discrepancy between expected and measured fetal size at the time of NT screening (r = 0.47, P<0.01 and r = 0.48, P<0.01, respectively)."
        ]
    },
    "9582182":
    {
        "question": "Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "llm_evidence": "The SCL-90-R (Symptom Checklist-90-Revised) includes an obsessive-compulsive dimension that assesses symptoms related to obsessive thoughts and compulsive behaviors. Research indicates that individuals who score high on this dimension often exhibit cognitive impairments, particularly in areas such as attention, executive function, and working memory. These cognitive deficits can manifest through difficulties in problem-solving, increased indecisiveness, and a tendency to engage in repetitive thinking patterns. Furthermore, studies have shown a correlation between high obsessive-compulsive scores and impairments in mental flexibility, which can hinder an individual's ability to adapt to new information or changing situations. Therefore, the SCL-90-R obsessive-compulsive dimension can serve as a useful tool in identifying cognitive impairments linked to obsessive-compulsive symptomatology.",
        "paper_evidence":
        [
            "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor.",
            "A prospective study of patients assessed with a neuropsychological test battery.",
            "A university medical center.",
            "Nineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy.",
            "Included in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory.",
            "The SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001)."
        ]
    },
    "25503376":
    {
        "question": "Does airway surgery lower serum lipid levels in obstructive sleep apnea patients?",
        "llm_evidence": "Airway surgery, particularly procedures like uvulopalatopharyngoplasty (UPPP) or maxillomandibular advancement (MMA), has been shown to improve respiratory function and reduce apnea events in patients with obstructive sleep apnea (OSA). This improvement in sleep quality and oxygenation can lead to metabolic changes, including reductions in serum lipid levels. \n\nResearch indicates that successful surgical outcomes in OSA patients often correlate with improvements in metabolic parameters, including lipid profiles. For example, studies have observed a decrease in total cholesterol, low-density lipoprotein (LDL), and triglycerides post-surgery, likely due to enhanced sleep quality and reduced oxidative stress associated with improved oxygenation levels during sleep.\n\nFurthermore, the relationship between sleep apnea and dyslipidemia is significant, as typical OSA pathophysiology contributes to insulin resistance and dysregulated lipid metabolism. By targeting and alleviating the obstructive component of sleep apnea, airway surgery can indirectly enhance lipid metabolism and help mitigate cardiovascular risks linked with dyslipidemia.\n\nIn conclusion, there is substantial evidence suggesting that airway surgery not only improves OSA symptoms but may also play a role in lowering serum lipid levels, thus benefiting overall metabolic health in these patients.",
        "paper_evidence":
        [
            "Obstructive sleep apnea (OSA) is tightly linked to increased cardiovascular disease. Surgery is an important method to treat OSA, but its effect on serum lipid levels in OSA patients is unknown. We aimed to evaluate the effect of upper airway surgery on lipid profiles.",
            "We performed a retrospective review of 113 adult patients with OSA who underwent surgery (nasal or uvulopalatopharyngoplasty [UPPP]) at a major, urban, academic hospital in Beijing from 2012 to 2013 who had preoperative and postoperative serum lipid profiles.",
            "Serum TC (4.86Â±0.74 to 4.69Â±0.71) and LP(a) (median 18.50 to 10.90) all decreased significantly post-operatively (P<0.01, 0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For UPPP patients (n=51), serum TC, HDL and LP(a) improved (P=0.01, 0.01,<0.01, respectively). For nasal patients (n=62), only the serum LP(a) decreased (P<0.01). In patients with normal serum lipids at baseline, only serum LP(a) decreased (P<0.01). In contrast, in patients with isolated hypertriglyceridemia, the serum HDL, TG and LP(a) showed significant improvements (P=0.02, 0.03,<0.01, respectively). In patients with isolated hypercholesterolemia, the serum LP(a) decreased significantly (P=0.01), with a similar trend for serum TC (P=0.06). In patients with mixed hyperlipidemia, the serum TC and LDL also decreased (P=0.02, 0.03, respectively)."
        ]
    },
    "21420186":
    {
        "question": "Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?",
        "llm_evidence": "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase, which plays a crucial role in endothelial function. Research indicates that elevated levels of ADMA are associated with endothelial dysfunction, which is a precursor to cardiovascular diseases. In young adults born preterm, studies have shown that they may exhibit differences in vascular health compared to those born at term, potentially due to factors such as altered growth patterns and increased inflammation during critical developmental periods.\n\nEvidence suggests that preterm birth is linked to long-term cardiovascular risk, and increased ADMA levels in this population can serve as a biomarker for early endothelial dysfunction. Specifically, young adults born preterm have demonstrated higher ADMA levels than their term counterparts, which correlates with impaired endothelial function as assessed by flow-mediated dilation and other vascular assessments.\n\nIn summary, ADMA levels in young adults born preterm may indeed serve as a predictive marker for early endothelial dysfunction, highlighting the importance of monitoring cardiovascular health in this at-risk population. Early identification of endothelial dysfunction through ADMA levels can facilitate preventive strategies to mitigate future cardiovascular issues.",
        "paper_evidence":
        [
            "Sporadic data present in literature report how preterm birth and low birth weight are risk factors for the development of cardiovascular diseases in later life. High levels of asymmetric dimethylarginine (ADMA), a strong inhibitor of nitric oxide synthesis, are associated with the future development of adverse cardiovascular events and cardiac death.",
            "1) to verify the presence of a statistically significant difference between ADMA levels in young adults born preterm at extremely low birth weight (<1000 g; ex-ELBW) and those of a control group of healthy adults born at term (C) and 2) to seek correlations between ADMA levels in ex-ELBW and anthropometric and clinical parameters (gender, chronological age, gestational age, birth weight, and duration of stay in Neonatal Intensive Care Unit).",
            "Thirty-two ex-ELBW subjects (11 males [M] and 21 females [F], aged 17-29years, mean age 22.2 Â± 2.3 years) were compared with 25 C (7 M and 18F). ADMA levels were assessed by high-performance liquid chromatography with highly sensitive laser fluorescent detection.",
            "ADMA levels were reduced in ex-ELBW subjects compared to C (0.606+0.095 vs 0.562+0.101 Î¼mol/L, p<0.05), and significantly correlated inversely with gestational age (r=-0.61, p<0.00001) and birth weight (r=-0.57, p<0.0002)."
        ]
    },
    "25725704":
    {
        "question": "Can clinical supervision sustain our workforce in the current healthcare landscape?",
        "llm_evidence": "Clinical supervision can play a vital role in sustaining the healthcare workforce in today's landscape by addressing key challenges such as staff burnout, skill development, and professional support. Research indicates that regular clinical supervision enhances job satisfaction, reduces turnover rates, and improves overall mental health among healthcare professionals. \n\nBy providing structured support, supervisors can help staff navigate the complexities of patient care, manage stress, and promote a culture of continuous learning. This, in turn, not only bolsters the emotional resilience of caregivers but also enhances patient safety and care quality. Furthermore, tailored supervision models can be adapted to meet the specific needs of diverse healthcare environments, making clinical supervision a scalable solution for workforce retention and development.\n\nOverall, investing in clinical supervision is essential in fostering a supportive work environment that prioritizes employee well-being, ultimately leading to a more stable and effective healthcare workforce.",
        "paper_evidence":
        [
            "Clinical supervision is widely recognised as a mechanism for providing professional support, professional development and clinical governance for healthcare workers. There have been limited studies about the effectiveness of clinical supervision for allied health and minimal studies conducted within the Australian health context. The aim of the present study was to identify whether clinical supervision was perceived to be effective by allied health professionals and to identify components that contributed to effectiveness. Participants completed an anonymous online questionnaire, administered through the health service's intranet.",
            "A cross-sectional study was conducted with community allied health workers (n = 82) 8 months after implementation of structured clinical supervision. Demographic data (age, gender), work-related history (profession employment level, years of experience), and supervision practice (number and length of supervision sessions) were collected through an online survey. The outcome measure, clinical supervision effectiveness, was operationalised using the Manchester Clinical Supervision Scale-26 (MCSS-26). Data were analysed with Pearson correlation (r) and independent sample t-tests (t) with significance set at 0.05 (ie the probability of significant difference set at P<0.05).",
            "The length of the supervision sessions (r(s) â‰¥ 0.44), the number of sessions (r(s) â‰¥ 0.35) and the total period supervision had been received (r(s) â‰¥ 0.42) were all significantly positively correlated with the MCSS-26 domains of clinical supervision effectiveness. Three individual variables, namely 'receiving clinical supervision', 'having some choice in the allocation of clinical supervisor' and 'having a completed clinical supervision agreement', were also significantly associated with higher total MCSS-26 scores (P(s)<0.014)."
        ]
    },
    "24516646":
    {
        "question": "Is the determination of specific IgE against components using ISAC 112 a reproducible technique?",
        "llm_evidence": "The determination of specific IgE against components using the ISAC 112 (ImmunoCAP Specific IgE Array) is considered a reproducible technique supported by several key insights:\n\n1. **Standardized Protocol**: ISAC 112 follows a standardized protocol for the measurement of specific IgE levels, ensuring consistency across different laboratories and tests.\n\n2. **Clinical Validation**: Numerous studies have demonstrated the clinical validity of the ISAC 112 methodology, showing reliable results that correlate well with traditional skin prick tests and other diagnostic methods.\n\n3. **Quality Control**: The ISAC platform incorporates robust quality control measures that enhance reproducibility, including internal controls and standardized sample handling procedures.\n\n4. **Multicenter Studies**: Research involving multiple centers has shown that the results obtained from ISAC 112 are reproducible, with minimal variation in IgE measurement among different settings.\n\n5. **Longitudinal Studies**: Longitudinal studies indicate that ISAC 112 can consistently detect changes in specific IgE levels over time, affirming its reliability for monitoring allergic conditions.\n\nOverall, the combined evidence from standardization, clinical validation, quality control, multicenter research, and longitudinal studies suggests that ISAC 112 is a reproducible technique for measuring specific IgE against components.",
        "paper_evidence":
        [
            "The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-batch- and inter-laboratory-assay.",
            "Twenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients' sera ten times in the same and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the calibration curve, and to analyse the repeatability and the reproducibility, we calculated the intraclass coefficient correlation (ICC) to each allergen.",
            "The results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra- and inter-assay analysis was very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens."
        ]
    },
    "22902073":
    {
        "question": "Estimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?",
        "llm_evidence": "Estimated fetal weight (EFW) measured by ultrasound can indeed be considered a modifiable risk factor for cesarean delivery (CD). Numerous studies suggest that inaccurate EFW estimation can lead to unnecessary cesarean sections, particularly in cases of suspected macrosomia (large fetal size). When EFW is overestimated, clinicians may opt for a cesarean delivery to avoid potential delivery complications, such as shoulder dystocia.\n\nMoreover, healthcare providers can use EFW data to engage in shared decision-making with patients about the timing and mode of delivery. For instance, if an ultrasound suggests a lower EFW than initially assessed, this could prompt a trial of labor versus a planned cesarean. \n\nAdditionally, factors such as maternal health, gestational diabetes management, and prenatal care can be modified to impact fetal growth and improve accuracy in EFW estimation. Therefore, by optimizing prenatal care and addressing maternal health conditions, the risks associated with inaccurate EFW assessments can be mitigated, leading to potential reductions in cesarean delivery rates. \n\nIn summary, EFW by ultrasound serves as a modifiable risk factor due to its implications on clinical decision-making and the ability to adjust prenatal care practices to influence outcomes.",
        "paper_evidence":
        [
            "The purpose of this study was to investigate whether knowledge of ultrasound-obtained estimated fetal weight (US-EFW) is a risk factor for cesarean delivery (CD).",
            "Retrospective cohort from a single center in 2009-2010 of singleton, term live births. CD rates were compared for women with and without US-EFW within 1 month of delivery and adjusted for potential confounders.",
            "Of the 2329 women in our cohort, 50.2% had US-EFW within 1 month of delivery. CD was significantly more common for women with US-EFW (15.7% vs 10.2%; P<.001); after we controlled for confounders, US-EFW remained an independent risk factor for CD (odds ratio, 1.44; 95% confidence interval, 1.1-1.9). The risk increased when US-EFW was>3500 g (odds ratio, 1.8; 95% confidence interval, 1.3-2.7)."
        ]
    },
    "23412195":
    {
        "question": "Should displaced midshaft clavicular fractures be treated surgically?",
        "llm_evidence": "Displaced midshaft clavicular fractures are commonly treated surgically, particularly in cases where the fracture is significantly displaced or associated with other complications. Key insights supporting surgical intervention include:\n\n1. **Non-Union Rates**: Surgical treatment, typically involving internal fixation with plates or intramedullary devices, has been shown to reduce the risk of non-union or malunion compared to conservative management. Non-union rates for displaced fractures treated non-operatively can be as high as 15-20%.\n\n2. **Functional Outcomes**: Studies indicate that surgical intervention leads to better functional outcomes and lower rates of complications such as shoulder stiffness and pain. Patients often report higher satisfaction with their results when fractures are surgically fixed.\n\n3. **Activity Level**: Active individuals, especially athletes, may require surgical treatment to restore shoulder mobility and strength effectively, allowing for a quicker return to their pre-injury activities.\n\n4. **Guidelines and Recommendations**: Consensus guidelines from orthopedic associations recommend surgical fixation for displaced midshaft fractures, particularly those with a shortening of the clavicle, severe displacement, or involvement of neurovascular structures.\n\n5. **Risk-Benefit Analysis**: While surgical treatment carries risks, including infection and hardware complications, the overall benefits in terms of alignment, stability, and recovery time often outweigh these risks for displaced fractures.\n\nIn conclusion, surgical treatment for displaced midshaft clavicular fractures is generally recommended to enhance healing, reduce complications, and improve functional outcomes, particularly in active patients or those with significant displacement.",
        "paper_evidence":
        [
            "This study was designed to compare clinical effectiveness of operative with nonoperative treatment for displaced midshaft clavicular fractures (DMCF).",
            "We systematically searched electronic databases (MEDILINE, EMBASE, CLINICAL, OVID, BIOSIS and Cochrane registry of controlled clinical trials) to identify randomized controlled trials (RCTs) in which operative treatment was compared with nonoperative treatment for DMCF from 1980 to 2012. The methodologic quality of trials was assessed. Data from chosen studies were pooled with using of fixed-effects and random-effects models with mean differences and risk ratios for continuous and dichotomous variables, respectively.",
            "Four RCTs with a total of 321 patients were screened for the present study. Results showed that the operative treatment was superior to the nonoperative treatment regarding the rate of nonunion [95Â % confidence interval (CI) (0.05, 0.43), PÂ =Â 0.0004], malunion [95Â % CI (0.06, 0.34), PÂ <Â 0.00001] and overall complication [95Â % CI (0.43-0.76), PÂ =Â 0.0001]. Subgroup analyses of complications revealed that significant differences were existed in the incidence of neurologic symptoms [95Â % CI (0.20, 0.74), PÂ =Â 0.004] and dissatisfaction with appearance [95Â % CI (0.19, 0.65), PÂ =Â 0.001]. Lack of consistent and standardized assessment data, insufficiency analysis that carried out showed improved functional outcomes (PÂ <Â 0.05) in operative treatment."
        ]
    },
    "9722752":
    {
        "question": "Does bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence?",
        "llm_evidence": "Bone anchor fixation has emerged as a notable technique in the surgical management of female stress urinary incontinence (SUI), particularly in the context of percutaneous bladder neck suspension procedures. Key insights supporting its effectiveness include:\n\n1. **Enhanced Stability**: Bone anchor fixation provides a more robust and stable platform for the bladder neck suspension compared to traditional methods that rely solely on soft tissue fixation. This stability is crucial in maintaining the position of the bladder neck, thereby reducing the likelihood of surgical failure.\n\n2. **Improved Outcomes**: Clinical studies have indicated that the use of bone anchor fixation is associated with higher success rates in terms of continence and lower rates of recurrence of incontinence compared to standard techniques. This improvement can be attributed to the secure anchorage provided by the bone fixation.\n\n3. **Decreased Complications**: With proper technique, bone anchored systems can reduce the risk of complications such as mesh erosion or infection, which are often associated with traditional mesh-based suspensions.\n\n4. **Long-Term Efficacy**: Evidence suggests that patients undergoing percutaneous bladder neck suspension with bone anchor fixation experience sustained improvement in urinary function over time, making it a favorable option for long-term management of SUI.\n\nOverall, the integration of bone anchor fixation into percutaneous bladder neck suspension appears to enhance surgical outcomes, making it a recommended approach for treating female stress urinary incontinence.",
        "paper_evidence":
        [
            "To evaluate the outcome of a new modification of percutaneous needle suspension, using a bone anchor system for fixing the suture at the public bone, and to compare the results with those published previously.",
            "From March 1996, 37 patients with stress urinary incontinence (>2 years) were treated using a bone anchor system. On each side the suture was attached to the pubocervical fascia and the vaginal wall via a broad 'Z'-stitch. A urodynamic investigation performed preoperatively in all patients confirmed stress incontinence and excluded detrusor instability. The outcome was assessed by either by a clinical follow-up investigation or using a standardized questionnaire, over a mean follow-up of 11 months (range 6-18).",
            "In the 37 patients, the procedure was successful in 25 (68%), with 16 (43%) of the patients completely dry and nine (24%) significantly improved. Removal of the bone anchor and suture was necessary in two patients, because of unilateral bacterial infection in one and a bilateral soft tissue granuloma in the other. One bone anchor became dislocated in a third patient. In two cases where the treatment failed, new detrusor instability was documented urodynamically. Minor complications were prolonged wound pain in 10 (26%) and transient urinary retention or residual urine in 12 patients (32%)."
        ]
    },
    "23870157":
    {
        "question": "Are intraoperative precursor events associated with postoperative major adverse events?",
        "llm_evidence": "A growing body of evidence suggests that intraoperative precursor events are significantly associated with postoperative major adverse events. Key insights include:\n\n1. **Definition and Identification**: Intraoperative precursor events typically refer to significant occurrences during surgery, such as hemodynamic instability, unexpected bleeding, or technical complications. Identifying these events is crucial for risk assessment.\n\n2. **Research Findings**: Several studies have shown that the presence of intraoperative complications correlates with higher rates of postoperative morbidity and mortality. For instance, a meta-analysis indicated that patients who experienced intraoperative adverse events had a substantially increased likelihood of facing major postoperative complications.\n\n3. **Mechanisms of Association**: The mechanisms underlying this association can be attributed to stress response, prolonged surgical duration, or compromised organ function, which can exacerbate recovery and increase instability following surgery.\n\n4. **Predictive Tools**: Some institutions have developed predictive models that incorporate intraoperative data to forecast postoperative outcomes. These tools can help identify high-risk patients and inform preventive strategies during surgery.\n\n5. **Clinical Implications**: Recognizing and addressing intraoperative precursor events can lead to improved postoperative outcomes, emphasizing the importance of vigilant monitoring and prompt intervention during surgical procedures.\n\nIn conclusion, the association between intraoperative precursor events and postoperative major adverse events is well-supported by research, highlighting the need for proactive management in the operating room to enhance patient outcomes.",
        "paper_evidence":
        [
            "Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement.",
            "The present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of â‰¥1 precursor events in the matched groups was performed.",
            "A total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; PÂ =Â .015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes."
        ]
    },
    "23848044":
    {
        "question": "Does oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?",
        "llm_evidence": "Oxybutynin hydrochloride is an anticholinergic medication primarily used to manage bladder dysfunction, particularly in cases of overactive bladder. While it is generally considered safe for use in children, there is some evidence suggesting that it may have cardiovascular effects, notably potential arrhythmias. \n\nKey insights include:\n\n1. **Mechanism of Action**: Oxybutynin works by inhibiting acetylcholine at muscarinic receptors, which can affect cardiac conduction. This mechanism raises the possibility of heart rhythm disturbances, particularly in sensitive populations such as children.\n\n2. **Clinical Studies**: Limited studies specifically focused on the pediatric population have raised concerns about the risk of tachycardia, a potential prelude to arrhythmias, especially with higher doses or prolonged use. Monitoring heart rate and rhythm may be advisable when prescribing.\n\n3. **Reports of Adverse Effects**: Some case reports and pharmacovigilance data have indicated instances of arrhythmia in patients taking oxybutynin, though these are rare. The relationship between oxybutynin and arrhythmias may also be confounded by underlying conditions in patients.\n\n4. **Comparative Safety**: In the overall spectrum of treatments for bladder dysfunction, oxybutynin is often compared with other anticholinergics, which also carry similar risks, albeit varying degrees based on individual patient profiles.\n\nIn conclusion, while oxybutynin hydrochloride is effective for treating bladder dysfunction in children, caution is warranted due to the potential but uncommon risk of arrhythmia. Regular monitoring and a thorough assessment of cardiovascular health are recommended when using this medication in pediatric patients.",
        "paper_evidence":
        [
            "This study represents a subset of a complete data set, considering only those children aged admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the period January 2011 to July 2012.",
            "In this study, we have determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children."
        ]
    },
    "9920954":
    {
        "question": "Do \"America's Best Hospitals\" perform better for acute myocardial infarction?",
        "llm_evidence": "Research and analyses have shown that hospitals designated as \"America's Best Hospitals\" tend to perform better in the treatment of acute myocardial infarction (AMI) compared to their non-ranked counterparts. Key insights include:\n\n1. **Quality Metrics**: Hospitals that receive accolades often exhibit superior metrics in clinical outcomes, including lower mortality rates and complication rates for AMI patients. These hospitals typically implement evidence-based protocols that improve care delivery.\n\n2. **Advanced Facilities**: America's Best Hospitals usually have access to advanced technologies and specialized cardiovascular teams, which can lead to quicker diagnoses and more effective treatments for heart attacks.\n\n3. **Research and Innovation**: Ranked hospitals are often involved in research and clinical trials, allowing them to stay at the forefront of innovative treatment options and best practices in cardiology, which can enhance patient outcomes.\n\n4. **Patient Volume and Experience**: Higher patient volumes at these hospitals contribute to greater experience and competence in managing AMI cases, further optimizing treatment pathways.\n\n5. **Patient Satisfaction**: These institutions typically score higher in patient satisfaction surveys, reflecting overall better care experience, which aligns with improved adherence to treatment protocols.\n\nOverall, the combination of superior resources, clinical expertise, and a commitment to quality care leads to better outcomes for patients suffering from acute myocardial infarction at America's Best Hospitals.",
        "paper_evidence":
        [
            "\"America's Best Hospitals,\" an influential list published annually by U.S. News and World Report, assesses the quality of hospitals. It is not known whether patients admitted to hospitals ranked at the top in cardiology have lower short-term mortality from acute myocardial infarction than those admitted to other hospitals or whether differences in mortality are explained by differential use of recommended therapies.",
            "Using data from the Cooperative Cardiovascular Project on 149,177 elderly Medicare beneficiaries with acute myocardial infarction in 1994 or 1995, we examined the care and outcomes of patients admitted to three types of hospitals: those ranked high in cardiology (top-ranked hospitals); hospitals not in the top rank that had on-site facilities for cardiac catheterization, coronary angioplasty, and bypass surgery (similarly equipped hospitals); and the remaining hospitals (non-similarly equipped hospitals). We compared 30-day mortality; the rates of use of aspirin, beta-blockers, and reperfusion; and the relation of differences in rates of therapy to short-term mortality.",
            "Admission to a top-ranked hospital was associated with lower adjusted 30-day mortality (odds ratio, 0.87; 95 percent confidence interval, 0.76 to 1.00; P=0.05 for top-ranked hospitals vs. the others). Among patients without contraindications to therapy, top-ranked hospitals had significantly higher rates of use of aspirin (96.2 percent, as compared with 88.6 percent for similarly equipped hospitals and 83.4 percent for non-similarly equipped hospitals; P<0.01) and beta-blockers (75.0 percent vs. 61.8 percent and 58.7 percent, P<0.01), but lower rates of reperfusion therapy (61.0 percent vs. 70.7 percent and 65.6 percent, P=0.03). The survival advantage associated with admission to top-ranked hospitals was less strong after we adjusted for factors including the use of aspirin and beta-blockers (odds ratio, 0.94; 95 percent confidence interval, 0.82 to 1.08; P=0.38)."
        ]
    },
    "20577124":
    {
        "question": "Is leptin involved in phagocytic NADPH oxidase overactivity in obesity?",
        "llm_evidence": "Leptin, a hormone produced by adipose tissue, plays a significant role in regulating energy balance and immune responses. In the context of obesity, elevated levels of leptin are associated with increased inflammation and oxidative stress. Research has shown that leptin can activate the NADPH oxidase complex in immune cells, leading to enhanced production of reactive oxygen species (ROS). This overactivity of NADPH oxidase contributes to the development of obesity-related chronic inflammation and can exacerbate metabolic disorders.\n\nKey insights supporting the involvement of leptin in phagocytic NADPH oxidase overactivity include:\n\n1. **Leptin and Immune Activation**: Leptin has been shown to promote the activation of various immune cells, including macrophages, which play a crucial role in phagocytosis and the inflammatory response.\n\n2. **ROS Production**: Studies indicate that the signaling pathways activated by leptin, such as those involving the Janus kinase/signal transducer and activator of transcription (JAK/STAT), stimulate NADPH oxidase activity, resulting in increased ROS production.\n\n3. **Obesity-induced Inflammation**: In obese individuals, the chronic elevation of leptin levels can lead to a persistent activation of phagocytic cells, thus enhancing oxidative stress through NADPH oxidase overactivity. This creates a feedback loop that aggravates inflammation and contributes to obesity-related metabolic complications.\n\nIn summary, the evidence supports that leptin is indeed involved in phagocytic NADPH oxidase overactivity in obesity, thereby linking obesity to heightened oxidative stress and inflammation through immune modulation.",
        "paper_evidence":
        [
            "Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients.",
            "The study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages.",
            "Phagocytic NADPH oxidase activity and leptin levels were enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation."
        ]
    },
    "17062234":
    {
        "question": "Surgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?",
        "llm_evidence": "Endoaortic balloon occlusion (EABO) is a technique used in surgical management of the atherosclerotic ascending aorta to minimize blood loss and prevent ischemic complications during procedures such as aneurysm repair or aortic valve replacement. Key insights regarding its safety and efficacy include:\n\n1. **Ischemia Prevention**: EABO effectively reduces blood flow to the ascending aorta, which can help limit myocardial ischemia during prolonged aortic clamping, thus enhancing cardiac protection.\n\n2. **Mortality and Complications**: Studies indicate that EABO can be associated with a lower incidence of stroke and myocardial infarction compared to traditional methods. Nonetheless, the safety profile can vary depending on patient selection and the presence of comorbidities.\n\n3. **Technical Considerations**: Proper placement and inflation of the balloon are crucial to avoid complications such as aortic dissection or balloon rupture. Inexperienced operators can pose risks, suggesting that institutional experience and expertise are vital.\n\n4. **Comparative Outcomes**: Comparison with other occlusion methods (e.g., cross-clamping) has shown that EABO may yield better hemodynamic stability and lower transfusion rates, enhancing postoperative recovery.\n\n5. **Patient Selection**: Candidate selection is critical; patients with significant aortic disease or prior surgeries may have an increased risk of complications. Careful preoperative planning and assessment are necessary.\n\nIn conclusion, while EABO is generally considered safe and can provide significant benefits in surgical management of atherosclerotic ascending aorta, its successful application hinges on appropriate patient selection, operator experience, and adherence to technical best practices. Continued advancements in techniques and outcomes data are essential for optimizing its use.",
        "paper_evidence":
        [
            "Occlusion of the atherosclerotic ascending aorta by an endoaortic inflatable balloon has been proposed as an alternative to conventional cross-clamping to prevent injury to the vessel and distal embolization of debris. The safety and the effectiveness of endoaortic occlusion have not been documented in this setting.",
            "Endoaortic occlusion was employed in 52 of 2,172 consecutive patients. Surgeon's choice was based on preoperative identification of aortic calcifications or intraoperative epiaortic ultrasonographic scanning. Deaths and strokes were analyzed casewise and in aggregate.",
            "In 10 patients (19.2%), the endoaortic balloon had to be replaced by the ordinary cross-clamp because of incomplete occlusion (n = 5), hindered exposure (n = 2), or balloon rupture (n = 3). In-hospital death occurred in 13 patients (25%), and stroke on awakening from anesthesia in 2 (3.8%). The death rate of patients treated by endoaortic occlusion was significantly higher compared with all other patients (4.2%, p<0.0001) and with the expected estimate by European System for Cardiac Operative Risk Evaluation (10.5%, p = 0.05). By multivariable analysis, use of endoaortic occlusion was independently associated with in-hospital death (odds ratio = 5.609, 95% confidence interval: 2.684 to 11.719). Although the stroke rate was higher in the endoaortic occlusion group compared with all other patients, the difference was only possibly significant (3.8% versus 0.8%, p = 0.067)."
        ]
    },
    "27131771":
    {
        "question": "Does left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?",
        "llm_evidence": "Left atrial appendage (LAA) occlusion devices are designed to reduce the risk of stroke in patients with atrial fibrillation (AF) by preventing thrombus formation in the LAA. Studies have shown that LAA occlusion can lead to significant changes in echocardiographic parameters. Post-procedure, patients often exhibit reductions in left atrial size and volume, which can correlate with improved cardiac function. Additionally, echocardiography may demonstrate a decrease in left atrial pressure, indicating better hemodynamics.\n\nElectrocardiogram (ECG) parameters may also be altered following LAA occlusion. Patients frequently show decreased episodes of AF or conversion to normal sinus rhythm post-procedure, which can improve overall heart rhythm stability. Moreover, there can be changes in heart rate variability and QT interval, reflecting improved cardiac autonomic function.\n\nOverall, LAA occlusion devices appear to have beneficial effects on both echocardiographic and electrocardiographic parameters in patients with AF, contributing to enhanced cardiac function and reduction in arrhythmia episodes.",
        "paper_evidence":
        [
            "The alterations of echocardiography and electrocardiogram (ECG) in patients received left atrial appendage LAA occlusion therapy are still unclear. The present study was to evaluate the influence of LAA occlusion device on echocardiography and ECG changes in patients with atrial fibrillation (AF).",
            "Seventy-three patients who had undergone Watchman, LAmbre and Lefort were enrolled in this study. Echocardiography and ECG results at pre- and post-operation were collected. Besides, echocardiography was also performed during follow-up visits at 1, 6 and 12months after discharge.",
            "After LAA occlusion, a slight and measureable movement of QRS electric axis was observed in most patients. The significant differences were also observed in heart rate (HR) and the mean-mean QT interval between pre- and post-operation for all patients. There existed no significant difference in echocardiographic parameters between before and after device implantation. However, a larger left atrial (LA) diameter was detected by echocardiography during follow-up visit at 6months when compared with pre-operation parameters. Similarly, aortic root diameter (ARD) was also larger during follow-up at 12months than the baseline dimension in pre-operation."
        ]
    }
}